A protein chimera self-assembling unit for drug delivery

Adriana Amalfitano, Cecilia Martini, Giuseppina Nocca, Massimiliano Papi, Marco De Spirito, Maurizio Sanguinetti, Alberto Vitali, Francesca Bugli, Alessandro Arcovito

Research output: Contribution to journalArticle

Abstract

In the modern view of selective drug delivery of bioactive molecules, the attention is moving onto the setup of the perfect carrier more than in the optimization of the active compound. In this respect, virus-like particles constitute bioinspired nanodevices with the intrinsic ability to transport a large class of molecules, ranging from smart drugs to small interfering RNAs. In this work, we demonstrate the efficacy of a novel construct obtained by fusing a self-assembling protein from the human Rotavirus A, VP6, with the Small Ubiquitin Modifier domain, which maintains the ability to form nanoparticles and nanotubes and is able to be used as a drug carrier, even without specific targeting epitopes. The high expression and purification yield, combined with low toxicity of the empty particles, clearly indicate a good candidate for future studies of selective drug delivery.

Original languageEnglish
JournalBiotechnology Progress
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Pharmaceutical Preparations
Nanotubes
Drug Carriers
Proteins
Rotavirus
Ubiquitin
Virion
Nanoparticles
Small Interfering RNA
Epitopes

Keywords

  • innovative biotechnologies
  • personalized medicine
  • targeted therapy
  • virus-like particles

ASJC Scopus subject areas

  • Biotechnology

Cite this

A protein chimera self-assembling unit for drug delivery. / Amalfitano, Adriana; Martini, Cecilia; Nocca, Giuseppina; Papi, Massimiliano; De Spirito, Marco; Sanguinetti, Maurizio; Vitali, Alberto; Bugli, Francesca; Arcovito, Alessandro.

In: Biotechnology Progress, 01.01.2018.

Research output: Contribution to journalArticle

Amalfitano, Adriana ; Martini, Cecilia ; Nocca, Giuseppina ; Papi, Massimiliano ; De Spirito, Marco ; Sanguinetti, Maurizio ; Vitali, Alberto ; Bugli, Francesca ; Arcovito, Alessandro. / A protein chimera self-assembling unit for drug delivery. In: Biotechnology Progress. 2018.
@article{220781b35dea4526a76b744e9f88e8ac,
title = "A protein chimera self-assembling unit for drug delivery",
abstract = "In the modern view of selective drug delivery of bioactive molecules, the attention is moving onto the setup of the perfect carrier more than in the optimization of the active compound. In this respect, virus-like particles constitute bioinspired nanodevices with the intrinsic ability to transport a large class of molecules, ranging from smart drugs to small interfering RNAs. In this work, we demonstrate the efficacy of a novel construct obtained by fusing a self-assembling protein from the human Rotavirus A, VP6, with the Small Ubiquitin Modifier domain, which maintains the ability to form nanoparticles and nanotubes and is able to be used as a drug carrier, even without specific targeting epitopes. The high expression and purification yield, combined with low toxicity of the empty particles, clearly indicate a good candidate for future studies of selective drug delivery.",
keywords = "innovative biotechnologies, personalized medicine, targeted therapy, virus-like particles",
author = "Adriana Amalfitano and Cecilia Martini and Giuseppina Nocca and Massimiliano Papi and {De Spirito}, Marco and Maurizio Sanguinetti and Alberto Vitali and Francesca Bugli and Alessandro Arcovito",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/btpr.2769",
language = "English",
journal = "Biotechnology Progress",
issn = "8756-7938",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - A protein chimera self-assembling unit for drug delivery

AU - Amalfitano, Adriana

AU - Martini, Cecilia

AU - Nocca, Giuseppina

AU - Papi, Massimiliano

AU - De Spirito, Marco

AU - Sanguinetti, Maurizio

AU - Vitali, Alberto

AU - Bugli, Francesca

AU - Arcovito, Alessandro

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In the modern view of selective drug delivery of bioactive molecules, the attention is moving onto the setup of the perfect carrier more than in the optimization of the active compound. In this respect, virus-like particles constitute bioinspired nanodevices with the intrinsic ability to transport a large class of molecules, ranging from smart drugs to small interfering RNAs. In this work, we demonstrate the efficacy of a novel construct obtained by fusing a self-assembling protein from the human Rotavirus A, VP6, with the Small Ubiquitin Modifier domain, which maintains the ability to form nanoparticles and nanotubes and is able to be used as a drug carrier, even without specific targeting epitopes. The high expression and purification yield, combined with low toxicity of the empty particles, clearly indicate a good candidate for future studies of selective drug delivery.

AB - In the modern view of selective drug delivery of bioactive molecules, the attention is moving onto the setup of the perfect carrier more than in the optimization of the active compound. In this respect, virus-like particles constitute bioinspired nanodevices with the intrinsic ability to transport a large class of molecules, ranging from smart drugs to small interfering RNAs. In this work, we demonstrate the efficacy of a novel construct obtained by fusing a self-assembling protein from the human Rotavirus A, VP6, with the Small Ubiquitin Modifier domain, which maintains the ability to form nanoparticles and nanotubes and is able to be used as a drug carrier, even without specific targeting epitopes. The high expression and purification yield, combined with low toxicity of the empty particles, clearly indicate a good candidate for future studies of selective drug delivery.

KW - innovative biotechnologies

KW - personalized medicine

KW - targeted therapy

KW - virus-like particles

UR - http://www.scopus.com/inward/record.url?scp=85059197886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059197886&partnerID=8YFLogxK

U2 - 10.1002/btpr.2769

DO - 10.1002/btpr.2769

M3 - Article

AN - SCOPUS:85059197886

JO - Biotechnology Progress

JF - Biotechnology Progress

SN - 8756-7938

ER -